Caricamento...
Ilixadencel – an Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration
Intratumoral administration of an immune primer is a therapeutic vaccine strategy aimed to trigger dendritic cell (DC)-mediated cross-presentation of cell-associated tumor antigens to cytotoxic CD8(+) T cells without the need for tumor antigen characterization. The prevailing view is that these cros...
Salvato in:
| Pubblicato in: | Pharm Res |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer US
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6002422/ https://ncbi.nlm.nih.gov/pubmed/29904904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-018-2438-x |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|